$AB

AllianceBernstein: Q2 Earnings Snapshot

AllianceBernstein Holding LP (AB) reported Q2 net income of $71.7 million, or 77 cents per share. Adjusted earnings were 82 cents per share. Revenue was $1.17 billion, with adjusted revenue of $887.5 million. The article notes AB shares down 1.5% YTD and 12% over 12 months.

Original reporting
Published Jul 28, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AB
Neutral
medium confidence
Mentioned
$AB
Relevance
6/10
alphai data visualization · based on local3news.com
Decision brief

The 30-second read

$ABNeutralMed
01

Why it matters

Traders can use the reported net income, EPS, and revenue figures to benchmark against expectations, but the article does not provide guidance or estimate context.

02

Market read

Earnings print may influence AB’s near-term valuation, but the lack of consensus and forward outlook reduces decision quality.

03

What to watch

Key items for asset managers are missing here, such as AUM, net flows, fee rate changes, and expense trends, which often explain earnings-driven moves.

Relevance 6/10Novelty 6/10Timing: after-hours earnings snapshot for Q2

Background

The piece is an AP-generated earnings snapshot for AllianceBernstein’s second quarter.

Company-level read

Ticker impact

$ABNeutralMedium confidence
Context

AllianceBernstein reported Q2 net income of $71.7 million, or 77 cents per share, and adjusted EPS of 82 cents.

Expected impact

Likely modest volatility around the earnings print, but direction is unclear without consensus or guidance.

Evidence & confidence

It includes hard financial figures but no guidance, margin detail, or analyst estimate comparison, limiting conviction on whether the print is a beat or miss.

Market effects

Adds another datapoint for the asset management earnings tape, but no sector-wide conclusions are drawn.

No specific regional demand or policy linkage is provided beyond the company’s Nashville base.

No international flows, macro drivers, or cross-border regulatory impacts are mentioned.

Counterpoint

Without consensus estimates, the earnings numbers alone may not justify a directional trade; price reaction could be driven by what was not reported (guidance, AUM, fees).

Key entities

  • AllianceBernstein Holding LP

    Reported Q2 net income of $71.7 million, EPS of 77 cents (82 cents adjusted), and revenue of $1.17 billion (adjusted $887.5 million).

Related articles

$ABMed

AllianceBernstein Holding L.P. Q2 2026 Earnings Call Summary

Strategic Execution and Platform Scaling Achieved record AUM of $905 billion, driven by a return to positive organic growth and the strongest gross sales quarter in five years. Reached the $90 billion to $100 billion private markets AUM target more than a year ahead of schedule, validating a multi-year investment strategy in corporate lending and real estate debt.

$ABMed

AllianceBernstein Holding LP (AB) Q2 2026 Earnings Call Highlights: Record AUM

AllianceBernstein (AB) discussed Q2 2026 earnings call topics, including expectations for the Equitable Corebridge merger to add about $100B of AUM over a couple of years, with combined general account assets around $350B and separate around $200B. Management cited resilient private wealth adviser productivity, reduced expense guidance by $5-10M, and demand shifts in U.S. taxable fixed income.

$ABMedAI 8/10

Advanced Bionics Receives FDA Approval for Expanded Cochlear Implant Candidacy Criteria in SSD and AHL

Advanced Bionics, a Sonova brand, said the US FDA approved expanded indications for its cochlear implant systems for single-sided deafness (SSD) and asymmetric hearing loss (AHL). The criteria broaden adult and pediatric eligibility, with company-cited research estimating 271,000 to 345,000 US adults with SSD and only 2.1% using CIs among eligible patients.

$ABMed

ALLIANCEBERNSTEIN HOLDING L.P. (AB): Results of Operations and Financial Condition

ALLIANCEBERNSTEIN HOLDING L.P. (AB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.01 2 a2q26earningsrelease.htm EX-99.01 2Q26 RELEASE Document Ioanis Jorgali, Investors 629.213.6139 ioanis.jorgali@alliancebernstein.com Carly Symington, Media 629.213.5568 carly.symington@alliancebernstein.com ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES SECOND QUARTER RESULTS

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.